Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:46:47 EDT Mon 09 Mar 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:QTRX - QUANTERIX CORPORATION - https://www.quanterix.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
QTRX - Q1.04.85·5.530.15.10+0.040.8686.13,0876,2024.85  5.18  4.818.77  4.0519:29:40Mar 0215 min RT 2¢

Recent Trades - Last 10 of 6202
Time ETExPriceChangeVolume
19:29:40Q5.090.03300
16:10:05Q5.100.041
16:10:04Q5.100.041
16:10:04Q5.100.041
16:08:38Q5.100.041
16:04:47Q5.100.041
16:04:34Q5.100.041
16:04:33Q5.100.041
16:04:15Q5.100.041
16:04:12Q5.100.041

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-03-02 16:01U:QTRXNews ReleaseQuanterix Releases Financial Results for the Fourth Quarter and Full Year 2025
2026-03-02 08:33U:QTRXNews ReleaseLucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide
2026-02-26 08:33U:QTRXNews ReleaseQuanterix to Participate in Upcoming Investor Conferences
2026-02-20 08:33U:QTRXNews ReleaseQuanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026
2026-02-03 08:33U:QTRXNews ReleaseQuanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer's Disease Detection
2026-01-21 08:33U:QTRXNews ReleaseQuanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer's Risk Profiling
2026-01-16 16:01U:QTRXNews ReleaseQuanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-01-08 16:30U:QTRXNews ReleaseQuanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
2025-12-22 07:30U:QTRXNews ReleaseQuanterix Announces Landmark Nature Study Redefining Alzheimer's Disease Neuropathology Prevalence
2025-11-20 16:15U:QTRXNews ReleaseQuanterix Announces Board and Leadership Changes to Support Next Stage of Growth
2025-11-17 17:30U:QTRXNews ReleaseQuanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring
2025-11-10 16:01U:QTRXNews ReleaseQuanterix Releases Financial Results for the Third Quarter of 2025
2025-11-03 07:00U:QTRXNews ReleaseQuanterix To Report Third Quarter 2025 Financial Results on November 10, 2025
2025-08-21 16:30U:QTRXNews ReleaseQuanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit
2025-08-11 07:00U:QTRXNews ReleaseQuanterix to Present at the Canaccord Genuity 45th Annual Growth Conference
2025-08-07 16:06U:QTRXNews ReleaseQuanterix Releases Financial Results for the Second Quarter of 2025
2025-08-04 16:02U:QTRXNews ReleaseQuanterix To Report Second Quarter 2025 Financial Results on August 7, 2025
2025-08-04 09:30U:QTRXNews ReleaseQuanterix Announces Cooperation Agreement with Kent Lake Capital
2025-07-28 07:00U:QTRXNews ReleaseQuanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC
2025-07-11 17:00U:QTRXNews ReleaseQuanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)